This Government Contract opportunity from Department Of Health And Human Services was posted on July 22, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Biostatistical Modeling and Causal Inference
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract seeks to develop and validate statistical models aimed at evaluating causal relationships between the use of GLP-1 receptor agonists and changes in outcomes related to HIV and alcohol and other substance use disorders, utilizing observational data and advanced analytical techniques. The work requires robust methodological expertise in causal inference, including but not limited to propensity score matching, instrumental variables, and doubly robust estimation, to account for confounding in non-randomized data and produce reliable estimates of treatment effects. The project is grounded in real-world health datasets and must deliver validated models capable of informing public health understanding and policy decisions regarding metabolic and addiction-related comorbidities. The contract is classified as a subcontract under the NAICS code 541611 for scientific research and development services, and is sponsored by the National Institutes of Health through the National Institute on Drug Abuse under the Department of Health and Human Services. The performance location is specified as Bethesda, Maryland, with a response deadline of July 30, 2026, and the opportunity was posted on July 22, 2026. While no set-aside type is indicated, the work demands specialized biostatistical capabilities and a proven track record in analyzing complex longitudinal health data to support rigorous causal analysis in the context of emerging pharmacotherapies and their downstream impacts on critical public health domains.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
This scope was carved out of 75N95026R0007.
The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.
Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
